TIDMULT

RNS Number : 7797W

Ultrasis PLC

03 January 2014

Ultrasis plc ("Ultrasis" or "the Company)

Dr John Martin to Retire as Executive Director in June 2014

Ultrasis today announce that Dr John 'Charlie' Martin, Executive Director, will retire from the Company and the Board of Ultrasis in June 2014 after 13 years of employment with the company.

"Charlie has contributed significantly to product development and the science behind our programmes and has taken lead responsibility for all matters of governance and research." said John Smith, Chief Executive at Ultrasis.

He added "We are grateful for all that Charlie has helped us to achieve and wish him well in his retirement. Charlie will remain as Executive Director until June 2014 to enable the Board to make suitable Operational and Executive arrangements."

Ends

Media enquiries:

For all enquiries relating to Ultrasis please contact

 
Ultrasis plc                 Tel: +44 (0) 20 7535 2050 
John Smith, Chief Executive 
 
finnCap Limited              Tel: +44 (0) 20 7220 0500 
Geoff Nash/Simon Hicks 
 
JBP Public Relations         Tel: +44 (0) 11 7907 3400 
Chris Lawrance 
 

Notes to Editors

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

For more information about Ultrasis please visit www.ultrasis.com

End

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAEADFAEDDLEFF

Ultrasis (LSE:ULT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Ultrasis
Ultrasis (LSE:ULT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Ultrasis